Core Program
Recognizing Obesity as a Chronic Disease - Part 1 Tiffany Lowe Clayton, DO, DABOM, MHPE This session will discuss the fundamental components of obesity as a chronic disease state. We will define obesity, discuss the many complexities of obesity as a disease and address how to approach the treatment of obesity in a comprehensive way to help patients obtain a healthier weight. Objectives:- Define obesity.
- Discuss the etiology of obesity.
- Discuss chronicity of obesity disease.
- Discuss the prevalence of obesity in different populations and subgroups.
Core Program
Recognizing Obesity as a Chronic Disease - Part 2 Lori Wenz, MSN, AGNP-C, BC-ADM, FOMA This session will review the physiological and psychological health risks associated with obesity, and will examine the impact that obesity has on society. The effect of weight bias and stigma on people living with obesity will be reviewed, and the use of people first language will be discussed. The importance of early diagnosis and treatment of obesity will be examined, and the chronic care model will be presented as appropriate approach to long term disease management. Objectives:- Describe health risks of obesity.
- Discuss weight bias/stigma and potential effects.
- Discuss importance of timely diagnosis and treatment for the disease of obesity.
Core Program
Obesity Physiology Harold Edward Bays MD, FOMA, FTOS, FACC, FNLA, FASPC What are the clinical realities of calories in versus calories out? What is the obesity "setpoint"? How does obesity cause metabolic disease? This session will discuss practical clinical applications of obesity physiology and pathophysiology. Objectives:- Describe components involved in normal body energy regulation.
- Discuss the function of the adipocyte in energy regulation.
- Discuss how weight and appetite are regulated.
Core Program
Obesity Pathophysiology Harold Edward Bays MD, FOMA, FTOS, FACC, FNLA, FASPC This session will further expand on the content from Session 3 and delve deeper into the pathophysiology of obesity. During this session, we will explore the foundational mechanisms of pathophysiology while also analyzing the roles played by the microbiome, sleep patterns, and body fat distribution in influencing both energy dysregulation and obesity. Objectives:- Describe the mechanisms of compromised energy regulation.
- Discuss energy dysregulation complications.
- Discuss the contribution of the microbiome, sleep, and body fat distribution in energy dysregulation.
- Discuss the role of genetics in energy dysregulation.
Core Program
Assessment and Diagnosis Angela Golden, DNP, FNP-C, FAANP, FOMA
Christy Davis, DNP, FNP-C This session will provide guidance for utilizing the current guidelines and algorithm to treat patients with pre-obesity (overweight) and obesity. A review of how obesity fits into a chronic care model will be discussed. Using case studies this session will demonstrate using screening tools and measurements to make a diagnosis and provide staging of the chronic disease of obesity. Objectives:- Describe the chronic care model and its relationship to obesity care.
- Discuss evidence-based guidelines for the disease of obesity.
- Discuss screening methodologies for overweight and obesity.
- Discuss the staging of obesity disease.
Core Program
Evaluation and Overview of Obesity Management Angela Golden, DNP, FNP-C, FAANP, FOMA This session will provide the participant with a blueprint for completing an assessment for a patient with obesity including a weight history, physical examination pertinent to obesity and the diagnostic workup. It will then move into important differential diagnosis and the conditions that obesity can cause and worsen. Finally, the session will end with the importance of using shared decision making in creating a plan of care using the information gleaned from the assessment to individualize the treatment plan. Objectives:- Describe components of assessment of the patient with obesity.
- Discuss considerations of the diagnostic work-up for the patient with obesity.
- Discuss obesity related conditions.
- Discuss shared decision-making process.
Core Program
Treatment Modalities and Interventions - Part 1 Angela Golden, DNP, FNP-C, FAANP, FOMA
Rebecca J. Graves, Ph.D., NP-C, FAANP Intensive Lifestyle Therapy (ILT) is a foundational component of healthcare for people with obesity. In this course, the treatment modalities and interventions for obesity (part 1), we will present the pillars of ILT that can be a part of the tool kit of every primary care provider when working with a person who has obesity. We will begin with a review of patient-centered care incorporating a shared decision making model based on evidence. Next, since obesity is a vastly multi-faceted disease, treatment and interventions should also be multi-faceted. Therefore, we will discuss behavioral, psycho-social, environmental, nutritional, and activity factors of ILT. During this course, we will also review barriers to factors of ILT that may prevent success and compliance and discuss ways to find solutions for barriers that cannot be modified. Finally, we will review strategies to facilitate healthy behavior change and on-going support of our patients. Objectives:- Describe components of Intensive Lifestyle Therapy (ILT).
- Discuss nutrition options included in ILT.
- Discuss potential activity barriers for the patient with obesity.
- Describe 3 communication strategies to aid development of ILT plan.
Core Program
Treatment Modalities and Interventions - Part 2 (Pharmacotherapy) Sandra Christensen, MSN, ARNP, FNP-BC, FOMA, FAANP Pharmacotherapy is one of the four pillars of evidence-based obesity treatment. Anti-obesity medications facilitate weight reduction that improves health. They are most effective when they are used as part of a comprehensive obesity treatment plan that includes nutritional therapy, physical activity, behavior modification, and bariatric surgery if indicated. Despite their safety and efficacy, only 1-3% of those eligible receive a prescription for FDA approved anti-obesity medications. This presentation will help you unlearn any outdated or biased beliefs about these medications and learn the latest science on how you can use them safely and effectively. Real-life clinical scenarios will help you learn how to select, initiate, titrate, and monitor these medications. Tips and strategies for personalized medication selection based on complications, co-existing conditions, symptoms, patient preference, cost, and insurance coverage will be provided. Objectives:- Describe 3 classes of weight promoting medications.
- Discuss the difference between FDA categories of "on-label" and "off-label".
- Identify the available FDA-approved anti-obesity medications, including mechanism of action, contraindications, interactions and adverse effects.
- Describe how to initiate, titrate and monitor response to medications, including criteria for continuation and discontinuation.
Core Program
Treatment Modalities and Interventions - Part 3 Lori Wenz, MSN, AGNP-C, BC-ADM, FOMA This session will discuss the role of devices, endoscopic procedures and metabolic and bariatric surgery in the treatment of obesity. Each treatment modality will be described and considerations for patient selection will be reviewed. The expected outcomes for each modality will be presented. Objectives:- Describe definition of device.
- Discuss difference between device and endoscopic procedure.
- Describe 2 most common metabolic and bariatric surgery (MBS) procedures in adults.
- Discuss outcomes from MBS procedures.
Obesity Care through the Lifespan
Practice Management Sandra Christensen, MSN, ARNP, FNP-BC, MFOMA, FAANP
Christina Nelson, MSN, ARNP, FNP-BC In this presentation, Sandra Christensen, an obesity medicine specialist with 20 years of experience, and Christina Nelson, a board-certified family nurse practitioner specializing in obesity medicine, discuss strategies for managing obesity as a chronic disease. They emphasize the importance of dedicated obesity-specific appointments, regular follow-ups (averaging 16 visits per year initially), and a chronic disease approach similar to managing diabetes or hypertension. Sam and Christina outline various practice models, including integrating obesity care into existing practices, creating separate programs, or establishing standalone clinics, with options for in-person, telehealth, or hybrid care. They highlight the four pillars of obesity treatment—nutrition, physical activity, behavioral counseling, and medical management—and offer practical guidance on structuring appointments, leveraging support staff or community resources, and optimizing clinical environments to be welcoming and accommodating. Billing and coding complexities are addressed, with updated ICD-10 codes introduced in October 2024 to support accurate, stigma-free documentation, alongside strategies for insurance-based or self-pay models to enhance patient access and outcomes. Objectives:- Describe different obesity treatment practice models.
- Discuss how to optimize practice environment to meet the needs of patients with obesity.
- Discuss importance of sensitivity training for all members of practice staff interfacing with patients with obesity.
- Understand the concepts of billing and coding for obesity management.
Obesity Care through the Lifespan
Pediatrics Evaluation and Assessment Sharon Karp, PhD, APRN, CPNP-PC, FAANP
Nancy Browne, MS, PPCNP-BC, FOMA, FAANP, FAAN Pediatric obesity is a multifaceted health issue that demands a nuanced and informed approach from healthcare providers. This engaging presentation will delve into key considerations that set obesity in children and adolescents apart from obesity in adults. A deeper understanding of these unique physiological factors, combined with current evidence-based guidelines, will empower healthcare professionals to offer more effective support to young patients and their families.
Initially, we will examine two critical physiological distinctions in pediatric obesity. Growing children experience dynamic hormonal fluctuations and metabolic shifts that significantly influence weight regulation. Additionally, the developing nervous system plays a pivotal role in controlling appetite and satiety signals, presenting differently in children compared to adults and requiring specialized clinical attention.
We will then review two influential evidence-based publications essential for guiding clinical practice. The American Academy of Pediatrics' clinical practice guideline provides a comprehensive framework for assessing, treating, and preventing pediatric obesity. Concurrently, the World Health Organization's report on ending childhood obesity outlines global strategies and policy recommendations essential for addressing this public health challenge. Lastly, we will highlight two clinical scenarios that should prompt consideration for genetic testing. Genetic conditions such as Prader-Willi syndrome and Bardet-Biedl syndrome can contribute to severe or early-onset obesity. Early recognition of these clinical patterns allows for timely genetic evaluation and personalized therapeutic strategies.
By exploring these critical nuances, healthcare providers can offer targeted, evidence-informed care, ultimately improving health outcomes and empowering young patients and their families on their journey toward wellness. Objectives:- Discuss 2 key concepts unique to pediatric population with implications for obesity care.
- Discuss 2 publications giving evidence based pediatric obesity care guidance.
- Describe 2 presentations suggestive of need for genetic testing in youth with obesity.
Obesity Care through the Lifespan
Pediatrics Foundational Obesity Care Sharon Karp, PhD, APRN, CPNP-PC, FAANP
Lisa Watson, MSN, APRN, CPNP-PC This presentation will provide an overview of key considerations in managing pediatric obesity, focusing on nutritional assessment, activity barriers, and psychosocial concerns. We will begin by discussing the essential components of nutritional assessment in the pediatric population. We will explore the importance of evaluating dietary intake, discuss barriers to dietary changes, and give practical strategies to promote healthy eating habits. We will address health-promoting measures of success that focus on overall health rather than weight. We will explore common concerns that hinder physical activity: psychological barriers, such as low self-esteem and body image issues, and environmental barriers, including access to recreational facilities and sedentary family habits. We will discuss practical strategies for promoting physical activity. Finally, we will explore psychosocial concerns faced by children and adolescents with obesity. We will highlight the effects of adverse childhood events (ACES) and bullying on obesity. We will also discuss the importance of screening for and preventing the onset of eating disorders. Lastly, we will discuss the risk of comorbid conditions, including depression and anxiety, and the importance of addressing these issues holistically.
By addressing these multifaceted aspects, healthcare providers can develop more comprehensive and effective interventions to support the long-term health and well-being of children and adolescents with obesity. Objectives:- Discuss 3 components of nutritional assessment in children with obesity.
- Discuss 2 concerns that may be barriers to activity in children with obesity.
- Discuss 3 potential psychosocial concerns for the child/adolescent with obesity.
Obesity Care through the Lifespan
Pediatrics Advanced Obesity Care Lisa Watson, MSN, APRN, CPNP-PC
Nancy Browne, MS, PPCNP-BC, FOMA, FAANP, FAAN This presentation will explore key considerations surrounding the use of FDA-approved therapies and interventions in the pediatric population, with a focus on anti-obesity medications and metabolic/bariatric surgery. We will begin by discussing the unique FDA safety and efficacy evaluation process for medications and devices intended for use in children and adolescents. This includes the assessment of age-appropriate dosing, potential differences in pharmacokinetics and pharmacodynamics, and the implementation of clinical trials specifically designed to capture the pediatric patient's experience. Next, we will discuss the use of anti-obesity medication, reviewing the safety profile of each treatment and discussing practical ways of implementing anti-obesity medications into practice. Finally, we will explore the outcomes of metabolic and bariatric surgery (MBS) in adolescent patients with severe obesity. This will include an overview of the safety profile, resolution of obesity-related comorbidities, and long-term impacts on growth and development, as well as the ethical considerations and patient selection criteria for these interventions. Objectives:- Discuss use of AOM use in children.
- Discuss weight promoting medication management in relation youth.
- Discuss FDA safety & efficacy process in relation to pediatric population.
- Discuss outcomes of MBS in adolescents with severe obesity.
Obesity Care through the Lifespan
Adults 18-40 Years Sandra Christensen, MSN, ARNP, FNP-BC, MFOMA, FAANP
Jennifer Kucera, MSN, APRN, FNP-C, FOMA In this presentation, Sandra Christensen, an obesity medicine specialist with 20 years of experience, and Jennifer Kucera, a board-certified family nurse practitioner specializing in obesity medicine, discuss obesity care for adults. Sam and Jennifer provide insights into conditions such as polycystic ovary syndrome (PCOS), obesity's impact on pregnancy and breastfeeding, and psychiatric conditions like anxiety, depression, and eating disorders. They also address sleep-related issues, including sleep apnea and shift work disorder, and their effects on metabolism and weight health. Case studies illustrate patient-centered approaches combining lifestyle modifications, medications, and behavioral support for weight management. Objectives:- Discuss reproductive considerations specific to the adult 18-40 living with obesity.
- Discuss sleep considerations specific to the adult 18-40 living with obesity.
- Discuss psychiatric considerations specific to the adult 18-40 living with obesity.
Obesity Care through the Lifespan
Adults 18-40 Years Sandra Christensen, MSN, ARNP, FNP-BC, MFOMA, FAANP
Jennifer Kucera, MSN, APRN, FNP-C, FOMA In this session, you will learn how to identify and address common obesity complications and conditions in adults ages 18-40, including cardiovascular disease, prediabetes/type 2 diabetes/insulin resistance, liver disease, psychiatric disease, sleep dysfunction/disorders, disordered eating/eating disorders, and musculoskeletal/mobility concerns. Evidence-based treatment strategies will be provided and integrated into case studies that will guide you in your clinical practice. Objectives:- Discuss cardiometabolic considerations specific to the adult 18-40 living with obesity.
- Discuss hepatic considerations specific to the adult 18-40 living with obesity.
- Discuss musculoskeletal considerations specific to the adult 18-40 living with obesity.
- Describe 2 factors related to sarcopenic obesity risk for the adult 18-40 living with obesity.
Obesity Care through the Lifespan
Adults 40-60 Years Sandra Christensen, MSN, ARNP, FNP-BC, MFOMA, FAANP
Christina Nelson, ARNP, MSN, FNP-BC This session will explore treatment considerations for the adult ages 40-60 including menopause, cardiometabolic risk, and sarcopenic obesity risk. You will learn how common obesity complications manifest in this stage of life. Topics include cardiovascular disease, prediabetes/type 2 diabetes/insulin resistance, liver disease, psychiatric disease, musculoskeletal/mobility concerns, urology issues, and cancer. Real-world case studies will translate the content into strategies you can implement in your clinical practice. Objectives:- Integrate cardiometabolic considerations specific to the adult 40-60 living with obesity.
- Evaluate hepatic considerations specific to the adult 40-60 living with obesity.
- Evaluate sleep considerations specific to the adult 40-60 living with obesity.
- Evaluate psychiatric considerations specific to the adult 40-60 living with obesity.
- Integrate menopausal considerations specific to the adult female 40-60 living with obesity.
Obesity Care through the Lifespan
Adults 60+ Years Angela Golden, DNP, FNP-C, FAANP, FOMA, FTOS Obesity rates for older adults have been increasing, with 42% of men and 46% of women over the age of 65 having obesity. Obesity is a risk factor for many of the chronic diseases of the geriatric population, including cardiometabolic issues, liver disease, musculoskeletal and mobility concerns and, of course, sleep dysfunction and dementia. This program will review the impact of obesity, including sarcopenic obesity, on people 60 and older. Objectives:- Discuss metabolic considerations specific to the adult 60+ living with obesity.
- Discuss hepatic considerations specific to the adult 60+ living with obesity.
- Discuss sleep considerations specific to the adult 60+ living with obesity.
- Discuss psychiatric considerations specific to the adult 60+ living with obesity.
Obesity Care through the Lifespan
Case Studies in Obesity and Diabetes in Adults Angela Golden, DNP, FNP-C, FAANP, FOMA, FTOS
Lori Wenz, AGNP-C, FOMA This course will incorporate case studies to examine the complex relationship between obesity and cardiometabolic diseases including insulin resistance, prediabetes and diabetes. Treatment options will be explored, incorporating current clinical guidelines to optimize health and patient outcomes. Objectives:- Discuss considerations, through case studies, related to the adult with obesity & diabetes/metabolic syndrome.
Obesity Care through the Lifespan
Case Studies in Obesity and Women's Health, Obesity and Men's Health Sandra Christensen, MSN, ARNP, FNP-BC, MFOMA, FAANP
Colleen Dawkins, FNP-C, RDN, CSOWM This session will highlight health concerns related to women’s health and men’s health for those living with obesity. Topics that will be integrated into real-world case studies for women include PCOS, infertility, pregnancy risks and complications, menstrual disorders, menopause, pelvic prolapse, and urinary stress incontinence. Case studies that address men’s health include hypoandrogenemia, hyperestrogenemia, low sperm count, infertility, and erectile dysfunction. Physical and psychological barriers to sexual activity for both sexes will be discussed. Objectives:- Discuss considerations, through case studies, related to women with obesity and men with obesity.
Obesity Care through the Lifespan
Case Studies in Under-Represented Populations Karli Burridge, PA-C, MMS, FOMA
Christy Davis, DNP, FNP-c In this presentation, Karli Burridge, physician associate and Fellow of the Obesity Medicine Association, and Christy Davis, Nurse Practitioner and metabolic medicine and obesity specialist, present best practices for managing obesity care in a clinical setting. Karli and Christy introduce different treatment models, emphasize the importance of a structured approach, and highlight the necessity of obesity-specific appointments. The speakers discuss integrating evidence-based treatment pillars—nutrition, physical activity, behavioral counseling, and medical management—into practice. This module also covers billing, coding, and reimbursement strategies, including Medicare and private insurance options. Finally, they underscore the importance of creating a welcoming, non-stigmatizing clinical environment and training staff on sensitivity and best practices for treating patients with obesity. Objectives:- Discuss considerations through case studies related to the under-represented populations with obesity including:
- Challenges in Obesity Care and specific issues faced by under-represented groups.
- Tailored Strategies for Patient-Centered Care and approaches to address unique needs.
|
Adding Registration, Please wait...
